GALTW
Galectin Therapeutics Inc. - Warrants
GALTW
GALTW
Delisted
GALTW was delisted on the 23rd of March, 2017.
4 hedge funds and large institutions have $3.87M invested in Galectin Therapeutics Inc. - Warrants in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Millennium Management
New York
|
$3.07M |
| 2 |
2
Neuberger Berman Group
New York
|
$750K |
Top Sellers
| 1 |
FNYS
1
First New York Securities
New York
|
$46K |
| 2 |
U
2
UBS
Zurich,
Switzerland
|
$0 |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$4K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| $3.07M | 569,000 | +286,352 | +101% |
|
|
2
Neuberger Berman Group
New York
| $750K | 138,900 | +2,000 | +1% |
|
|
FNYS
3
First New York Securities
New York
| $46K | 8,500 | -65,755 | -89% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $4K | 670 | -80 | -11% |
|
|
U
5
UBS
Zurich,
Switzerland
| – | – | -1,187 | Closed |
|